Cervical cancer clinical trials

Explore recruiting cervical cancer clinical trials.

Recruiting cervical cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cervical cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Open-label, Phase 2 Basket Study of MK‑7684A, a Co formation of Vibostolimab (MK‑7684) With Pembrolizumab (MK‑3475), With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (KEYVIBE 005)

Spain, Italy, Germany, Poland, France, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Prospective randomized study on sexual health and self-perceived quality of life (PROMs) in patients treated for cervical cancer

Spain

Therapeutic use (Phase IV) EU CTIS Study details

C5721002 _ A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator’s Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer

Sweden, Czechia, Finland, Netherlands, Hungary, Norway +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

FIGO 2018 stage IB2 (>2 cm - ≤4 cm ) Cervical Cancer Treated with Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery (CoNteSSa) / Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NeoCon-F)

Netherlands, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Induction chemotherapy followed by standard concurrent chemoradiotherapy in cervical cancer with para-aortic lymph node involvement: A phase III, multicenter, parallel-group randomized, controlled trial - ONCOCOL-01

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase III, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy of pre-surgical HPV9-valente vaccination in women treated with loop electrosurgical excision (LEEP) for high-grade cervical intraepithelial neoplasia (CIN2+) up to cervical cancer initially invasive (FIGO IA1) - HOPE 9 STUDY

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Cervical cancer trials by city

Cervical cancer in Toronto Cervical cancer in Vancouver Cervical cancer in Montreal Cervical cancer in Calgary Cervical cancer in Edmonton Cervical cancer in Ottawa Cervical cancer in Winnipeg Cervical cancer in Quebec City Cervical cancer in Hamilton Cervical cancer in Kitchener Cervical cancer in London Cervical cancer in Halifax Cervical cancer in New York Cervical cancer in Los Angeles Cervical cancer in Chicago Cervical cancer in Houston

Other conditions

Colorectal cancer Pancreatic cancer Ovarian cancer Melanoma Leukemia Lymphoma Multiple myeloma Bladder cancer Kidney cancer Liver cancer Glioblastoma Head and neck cancer Endometrial cancer Gastric cancer Age-related macular degeneration Diabetic retinopathy Glaucoma Dry eye disease HIV Hepatitis B Hepatitis C COVID-19 Influenza RSV